Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice.
about
Creatine for treating muscle disordersCreatine for treating muscle disordersCreatine for treating muscle disordersAutomated drug screening with contractile muscle tissue engineered from dystrophic myoblastsInvestigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophyOxidative Stress-Mediated Skeletal Muscle Degeneration: Molecules, Mechanisms, and TherapiesMetabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular DystrophyBeneficial effects of a Q-ter based nutritional mixture on functional performance, mitochondrial function, and oxidative stress in ratsLack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.Attempting to Compensate for Reduced Neuronal Nitric Oxide Synthase Protein with Nitrate Supplementation Cannot Overcome Metabolic Dysfunction but Rather Has Detrimental Effects in Dystrophin-Deficient mdx Muscle.The different impact of a high fat diet on dystrophic mdx and control C57Bl/10 miceCreatine, L-carnitine, and ω3 polyunsaturated fatty acid supplementation from healthy to diseased skeletal muscle.Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency.Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice.Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea.Age-related T2 changes in hindlimb muscles of mdx mice.Therapeutics in duchenne muscular dystrophy.Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophyThe potential benefits of creatine and conjugated linoleic acid as adjuncts to resistance training in older adults.Creatine as a therapeutic strategy for myopathies.Nutrition strategies to improve physical capabilities in Duchenne muscular dystrophy.Nutrition Considerations in Duchenne Muscular Dystrophy.New insights into the trophic and cytoprotective effects of creatine in in vitro and in vivo models of cell maturation.Effect of creatine and pioglitazone on Hk-2 cell line cisplatin nephrotoxicity.Histological assessment of intermediate- and long-term creatine monohydrate supplementation in mice and rats.Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice.The effect of creatine supplementation on myocardial function, mitochondrial respiration and susceptibility to ischaemia/reperfusion injury in sedentary and exercised rats.Loss of MKP-5 promotes myofiber survival by activating STAT3/Bcl-2 signaling during regenerative myogenesis.Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.New creatine transporter assay and identification of distinct creatine transporter isoforms in muscle.Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats.Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study.Phosphocreatine as an energy source for actin cytoskeletal rearrangements during myoblast fusion.Dietary NaCl supplementation prevents muscle necrosis in a mouse model of Duchenne muscular dystrophy.Focusing on fibrosis: halofuginone-induced functional improvement in the mdx mouse model of Duchenne muscular dystrophy.Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy.Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls.The effect of taurine and β-alanine supplementation on taurine transporter protein and fatigue resistance in skeletal muscle from mdx mice.
P2860
Q24202243-1845BCD8-DACD-4623-9CF2-751A0143124EQ24236598-0245AA69-0B07-43B6-A425-98B08468FB0DQ24246414-84FD616A-1B50-407D-BCFE-95910AF86F18Q24629251-C306A63A-F786-45B3-8844-8B700666C308Q24644090-C6032D57-3334-481E-86CB-9E819A08E0E3Q26769962-530A3029-AD7B-4F59-A2A5-3AE71D7C570DQ26772002-3E6B7EE5-AD68-4231-BAC5-1D57ADD13E18Q28473890-EB6D1391-7F25-4670-BFAD-0464AC7D68B1Q33440579-718786AC-B15F-4F8B-B91C-83E9A1E09123Q33586004-C77363B7-1368-4933-97B1-F05EF936F15CQ34077151-5C02BFFF-F340-4F75-B718-3CECE41986D1Q34177044-A6ACB09F-C05D-446B-AB0E-DCC828D08F33Q34776381-7C843585-99FF-4E91-85DA-1FC341455B4BQ35087995-E9478BD6-96EB-4B3D-B284-6AC2C0941428Q35962987-DB4CFCAF-998E-4644-822B-AED3FA4EBBF2Q36145433-C302E673-614F-4A95-88B5-C9FAC3444869Q36428758-98D951E0-FD1B-4A62-B3EF-50B0C3FC201BQ36841572-2E35F30A-495E-425C-A3F5-1DE7D24F8245Q37112576-EE4FE599-0DBD-4033-AF4F-061C06B686E5Q37852586-88270E83-E696-472D-BEBD-E632D733E55CQ37975321-4361DB33-D030-46C3-B284-AC272BC14CDFQ38482328-A0937368-73A2-4D18-B72F-0401B02DD81CQ38685353-339BD015-2CE7-47D3-9028-88B2B6D3A221Q38983939-0E51485F-AA8E-4CF4-9286-CC53F58FAB1EQ39125775-7E38A6FE-683F-404B-A8FF-FB99CBB447B9Q39330717-964AA11B-F7FF-4EE7-903C-D4DD0649CF12Q41887615-88EB27EF-A5C6-445F-A697-82715AC11788Q42508767-B2FF79A1-558D-46B5-9A5D-5CD2C1197F9FQ42672321-0328E592-F1A7-4E2C-B21C-B6F06EED0ECFQ43884201-3A60FDDD-6A32-46FD-A551-0554EDA25E01Q44058344-05287550-3FF9-4E7F-B393-2A801A1CEB63Q44227855-4ED9170C-C16F-451F-8610-DF61D1596863Q44350621-56887689-DD28-45A2-B493-6DB8D171054FQ46416690-B9B0EA66-3D44-4B9E-9D86-5AF4DADACE44Q46638345-24F90A17-33DC-4116-AB88-A54D5592F8A7Q46716710-222FBE00-B561-40DC-BD81-C846CCF6A4E5Q46725755-401A84CF-A6BB-45AE-914A-651E4098FB1AQ46887832-A1BD81B1-8BB7-451F-8DFA-08E3201FBD57Q47811763-0EDDC855-A016-4688-927B-AC582495D9D6Q51625827-0AE0BEF2-0B96-49E8-A671-74DE49C85AE9
P2860
Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Creatine supplementation reduc ...... hondrial function in mdx mice.
@en
Creatine supplementation reduc ...... hondrial function in mdx mice.
@nl
type
label
Creatine supplementation reduc ...... hondrial function in mdx mice.
@en
Creatine supplementation reduc ...... hondrial function in mdx mice.
@nl
prefLabel
Creatine supplementation reduc ...... hondrial function in mdx mice.
@en
Creatine supplementation reduc ...... hondrial function in mdx mice.
@nl
P2093
P1476
Creatine supplementation reduc ...... hondrial function in mdx mice.
@en
P2093
Anne-Catherine Passaquin
Armand Mokhtarian
Corinne Challet
Laurence Kay
Mathilde Renard
Urs T Ruegg
P304
P356
10.1016/S0960-8966(01)00273-5
P577
2002-02-01T00:00:00Z